Shenzhen Stock Exchange:
China International Capital Corporation Limited
Report on the 2025 Continuous Supervision Training of Beijing Remeet Medical Technology Co., Ltd.
China International Capital Corporation Limited (hereinafter referred to as "CICC" or "Sponsor") hereby reports on the 2025 continuous supervision training conducted for the controlling shareholders, actual controllers, directors, senior management, and key personnel of Beijing Remeet Medical Technology Co., Ltd. (hereinafter referred to as "Remeet" or "the Company"), in accordance with the requirements of relevant laws and regulations such as the "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 13 - Sponsorship Business" and the "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 2 - Normative Operation of GEM Listed Companies."